Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
At Emory Winship Cancer Institute, we provide exceptional expertise in the management of a variety of plasma cell disorders, and diseases related to plasma cell abnormalities. Our specialists in the plasma cell dyscrasia program at Winship are ready to provide you with the most advanced treatment options available today.
There are several differing types of plasma cell disorders, or diseases related to plasma cell abnormalities. In our clinic, we treat patients with any one of the following:
The team includes healthcare professionals in the following areas:
Hematology and Oncology:
Jonathan L. Kaufman, MD; Craig C. Hofmeister, MD, MPH
Gastroenterology:
Nikrad Shahnavaz, MD
Cardiology:
Kunal Bhatt, MD
Related Content
-
On-Demand COVID-19 Preparedness WebinarThis discussion was recorded on March ...
-
Symptom Management in Amyloid Neuropathy – ASG Webinar 8/11https://www.youtube.com/watch?v=K2TmwAfu...
-
Mayo Clinic Patient Symposium in Plasma Cell Disorders 2021: Patient and Family RegistrationMayo Clinic School of Continuous Profess...
-
Amyloidosis AllianceThe goal of Amyloidosis Alliance is to m...
-
Taste of Ocean City & Slide for AmyloidosisTaste of Ocean City (OC) is an event wit...
-
Cerebral Amyloid Angiopathy Research CenterCerebral Amyloid Angiopathy Research Cen...
-
Patient Access Network (PAN) FoundationThe PAN Foundation is an independent, ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.